Literature DB >> 12830140

DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses.

Reuben S Harris1, Ann M Sheehy, Heather M Craig, Michael H Malim, Michael S Neuberger.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12830140     DOI： 10.1038/ni0703-641

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  45 in total

1.  Postinternalization inhibition of adenovirus gene expression and infectious virus production in human T-cell lines.

Authors:  Adrienne L McNees; Jeff A Mahr; David Ornelles; Linda R Gooding
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

2.  Protein tolerance to random amino acid change.

Authors:  Haiwei H Guo; Juno Choe; Lawrence A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-14       Impact factor: 11.205

3.  Multiple fates of L1 retrotransposition intermediates in cultured human cells.

Authors:  Nicolas Gilbert; Sheila Lutz; Tammy A Morrish; John V Moran
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 4.  APOBEC family proteins: novel antiviral innate immunity.

Authors:  Akifumi Takaori-Kondo
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

Review 5.  Studies of endogenous retroviruses reveal a continuing evolutionary saga.

Authors:  Jonathan P Stoye
Journal:  Nat Rev Microbiol       Date:  2012-05-08       Impact factor: 60.633

Review 6.  Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Authors:  Belete A Desimmie; Krista A Delviks-Frankenberrry; Ryan C Burdick; DongFei Qi; Taisuke Izumi; Vinay K Pathak
Journal:  J Mol Biol       Date:  2013-11-02       Impact factor: 5.469

7.  Nucleic acid recognition orchestrates the anti-viral response to retroviruses.

Authors:  Spyridon Stavrou; Kristin Blouch; Swathi Kotla; Antonia Bass; Susan R Ross
Journal:  Cell Host Microbe       Date:  2015-03-26       Impact factor: 21.023

8.  Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect.

Authors:  Yasumasa Iwatani; Hiroaki Takeuchi; Klaus Strebel; Judith G Levin
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

9.  APOBEC3G targets specific virus species.

Authors:  Masayuki Kobayashi; Akifumi Takaori-Kondo; Keisuke Shindo; Aierken Abudu; Keiko Fukunaga; Takashi Uchiyama
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV-1 replication results in levels of G-to-A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNA.

Authors:  Rebecca A Russell; Michael D Moore; Wei-Shau Hu; Vinay K Pathak
Journal:  Retrovirology       Date:  2009-02-13       Impact factor: 4.602
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.